This article is more than 5 years old. Information may no longer be current.
UT Health cancer center names director
Click Here to Manage Email Alerts
Ruben A. Mesa, MD, has been named director of UT Health San Antonio Cancer Center.
The NCI–designated cancer center is part of UT Health San Antonio, a component of The University of Texas System.
Mesa, a HemOnc Today Editorial Board member, serves as chair of the division of hematology and medical oncology at Mayo Clinic in Arizona and deputy director of Mayo Clinic Cancer Center.
He will assume his new role in August.
“We are pleased to welcome Dr. Mesa to our cancer center, to UT Health and to San Antonio,” William L. Henrich, MD, MACP, president of The University of Texas Health Science Center, said in a press release. “In addition to his superb leadership, Dr. Mesa is an international expert on myeloproliferative neoplasms and will bring with him a sizeable patient-centered research program to San Antonio.”
Mesa has been involved in research related to myeloproliferative neoplasms for more than 20 years. He served as principal or co-principal investigator on more than 70 clinical trials.
He began his career with Mayo Clinic in 1991, starting in Rochester, Minnesota, before moving to the Arizona campus 8 years ago.
“San Antonio is a warm, unique community and I look forward to working with colleagues whose commitment aligns with putting patients first and continually striving to alleviate the burden of cancer through the highest-quality patient care, scientific discovery and integrity, and providing a medical education with clear distinction in new, innovative models for clinical education,” Mesa said in the press release.
“We are aligned in our mission to end cancer,” Mesa added. “We will continue to make life-changing breakthroughs in cancer research and care for Texans and beyond. This is an exceptional opportunity to take full advantage of the tremendous assets of the UT Health Cancer Center and our affiliation with [The University of Texas] MD Anderson Cancer Center to defeat this disease.”